M. Vermeulen-Spohn
Papers
2
Total Citations
10
H-Index
2
About
M. Vermeulen-Spohn is a pioneering urologic oncologist whose research focuses on advancing minimally invasive surgical techniques for testicular and germ cell tumors. Their major contributions center on demonstrating the peri-operative and oncological safety of robot-assisted retroperitoneal lymph node dissection (R-RPLND) compared to traditional open surgery. In their landmark 2025 matched-pair analysis (7 citations), they provided compelling evidence that the robotic approach offers comparable oncological outcomes with reduced surgical morbidity, helping to shift the standard of care toward less invasive options. Vermeulen-Spohn is also leading the innovative RAISN trial (2024, 3 citations), which investigates robot-assisted sentinel lymph node biopsy using indocyanine green fluorescence to detect occult metastatic disease in clinical stage I testicular cancer. This work represents a significant step toward personalized, image-guided staging that could spare many patients from unnecessary lymph node dissections. By combining robotics with real-time lymphatic mapping, Vermeulen-Spohn is at the forefront of redefining surgical precision in germ cell tumor management, with their early but impactful studies already shaping clinical practice and inspiring further investigation into targeted, minimally invasive oncologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2